BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18094669)

  • 1. Drug-eluting stent pathology--should we still be cautious?
    Nakazawa G; Finn AV; Virmani R
    Nat Clin Pract Cardiovasc Med; 2008 Jan; 5(1):1. PubMed ID: 18094669
    [No Abstract]   [Full Text] [Related]  

  • 2. Late stent thrombosis after drug-eluting stent implantation for acute myocardial infarction: a new red flag is raised.
    Pfisterer ME
    Circulation; 2008 Sep; 118(11):1117-9. PubMed ID: 18779453
    [No Abstract]   [Full Text] [Related]  

  • 3. Are drug-eluting stents safe?: Definitely! Or probably... possibly? Or maybe not yet...
    Nakazawa G; Ladich E; Virmani R
    Clin Pharmacol Ther; 2009 Aug; 86(2):127-30. PubMed ID: 19621005
    [No Abstract]   [Full Text] [Related]  

  • 4. Stent thrombosis: an overview.
    Centemero MP; Stadler JR
    Expert Rev Cardiovasc Ther; 2012 May; 10(5):599-615. PubMed ID: 22651836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-eluting stent thrombosis.
    Stähli BE; Camici GG; Tanner FC
    Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):45-52. PubMed ID: 19124388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug eluting stents in AMI: keep the data coming.
    Vetrovec GW
    Catheter Cardiovasc Interv; 2008 May; 71(6):770-1. PubMed ID: 18412075
    [No Abstract]   [Full Text] [Related]  

  • 7. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study.
    Nakazawa G; Finn AV; Joner M; Ladich E; Kutys R; Mont EK; Gold HK; Burke AP; Kolodgie FD; Virmani R
    Circulation; 2008 Sep; 118(11):1138-45. PubMed ID: 18725485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The problem of stent thrombosis associated with drug-eluting stents and the optimal duration of dual antiplatelet therapy.
    Ayyanathan S; Hersh D; Coplan NL; Garratt K
    Prev Cardiol; 2009; 12(2):59-64. PubMed ID: 19476578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of stent thrombosis, myocardial infarction, and mortality following drug-eluting versus bare-metal stent coronary intervention in patients with diabetes mellitus.
    Maeng M; Jensen LO; Kaltoft A; Hansen HH; Bøttcher M; Lassen JF; Thayssen P; Krusell LR; Rasmussen K; Pedersen L; Sørensen HT; Johnsen SP; Thuesen L
    Am J Cardiol; 2008 Jul; 102(2):165-72. PubMed ID: 18602515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Anti-healing" versus "pro-healing".
    Seth DA
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):605-6. PubMed ID: 18360850
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stent thrombosis: a poor man's disease?
    Danenberg HD; Marincheva G; Varshitzki B; Nassar H; Lotan C
    Isr Med Assoc J; 2009 Sep; 11(9):529-32. PubMed ID: 19960845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter by Testa et al regarding article, "Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization".
    Testa L; van Gaal WJ; Bhindi R
    Circulation; 2007 Nov; 116(22):e549; author reply e550. PubMed ID: 18040034
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.
    Piscione F; Piccolo R; Cassese S; Galasso G; Chiariello M
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):323-32. PubMed ID: 19360858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
    Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-eluting stent thrombosis: it's never too late.
    Kandzari DE
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):638-9. PubMed ID: 17122791
    [No Abstract]   [Full Text] [Related]  

  • 17. Late thrombosis of paclitaxel-eluting stents: long-term incidence, clinical consequences, and risk factors in a cohort of 604 patients.
    Flores-Ríos X; Marzoa-Rivas R; Abugattás-de Torres JP; Piñón-Esteban P; Aldama-López G; Salgado-Fernández J; Calviño-Santos R; Vázquez-Rodríguez JM; Vázquez-González N; Castro-Beiras A
    Am Heart J; 2008 Apr; 155(4):648-53. PubMed ID: 18371471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SES for AMI: moving in the right direction.
    Vetrovec GW
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):333-4. PubMed ID: 19642181
    [No Abstract]   [Full Text] [Related]  

  • 19. Preclinical and early clinical experience with a biodegradable polymer-based, rapamycin-eluting, Indian drug-eluting coronary stent: the BIO-RAPID study.
    Bhargava B; Karthikeyan G; Shankar PB; Seth S; Singh S; Pr U; Lal AV; Mohanty M
    Indian Heart J; 2008; 60(3):228-32. PubMed ID: 19240312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation.
    Kimura T; Morimoto T; Nakagawa Y; Tamura T; Kadota K; Yasumoto H; Nishikawa H; Hiasa Y; Muramatsu T; Meguro T; Inoue N; Honda H; Hayashi Y; Miyazaki S; Oshima S; Honda T; Shiode N; Namura M; Sone T; Nobuyoshi M; Kita T; Mitsudo K;
    Circulation; 2009 Feb; 119(7):987-95. PubMed ID: 19204304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.